In summary, the data of our present study revealed a synergistic, or at least a beneficial additive, effect of the combination of metformin and pioglitazone on the improvement of glucose and lipid metabolism and insulin sensitivity in HFD-induced obesity and IR mice. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.